| Product Code: ETC12366981 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Hemophilia Gene Therapy Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Hemophilia Gene Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 China Hemophilia Gene Therapy Market - Industry Life Cycle |
3.4 China Hemophilia Gene Therapy Market - Porter's Five Forces |
3.5 China Hemophilia Gene Therapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 China Hemophilia Gene Therapy Market Revenues & Volume Share, By Hemophilia Type, 2021 & 2031F |
3.7 China Hemophilia Gene Therapy Market Revenues & Volume Share, By Administration Method, 2021 & 2031F |
3.8 China Hemophilia Gene Therapy Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 China Hemophilia Gene Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hemophilia in China |
4.2.2 Advances in gene therapy technology and research |
4.2.3 Growing investments in healthcare infrastructure and RD in China |
4.3 Market Restraints |
4.3.1 High cost associated with gene therapy treatments |
4.3.2 Regulatory challenges and approval processes for gene therapies in China |
5 China Hemophilia Gene Therapy Market Trends |
6 China Hemophilia Gene Therapy Market, By Types |
6.1 China Hemophilia Gene Therapy Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 China Hemophilia Gene Therapy Market Revenues & Volume, By Therapy Type, 2021 - 2031F |
6.1.3 China Hemophilia Gene Therapy Market Revenues & Volume, By Gene Replacement Therapy, 2021 - 2031F |
6.1.4 China Hemophilia Gene Therapy Market Revenues & Volume, By Gene Editing Therapy, 2021 - 2031F |
6.1.5 China Hemophilia Gene Therapy Market Revenues & Volume, By RNA Interference Therapy, 2021 - 2031F |
6.2 China Hemophilia Gene Therapy Market, By Hemophilia Type |
6.2.1 Overview and Analysis |
6.2.2 China Hemophilia Gene Therapy Market Revenues & Volume, By Hemophilia A, 2021 - 2031F |
6.2.3 China Hemophilia Gene Therapy Market Revenues & Volume, By Hemophilia B, 2021 - 2031F |
6.2.4 China Hemophilia Gene Therapy Market Revenues & Volume, By Acquired Hemophilia, 2021 - 2031F |
6.3 China Hemophilia Gene Therapy Market, By Administration Method |
6.3.1 Overview and Analysis |
6.3.2 China Hemophilia Gene Therapy Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3.3 China Hemophilia Gene Therapy Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.3.4 China Hemophilia Gene Therapy Market Revenues & Volume, By Intradermal, 2021 - 2031F |
6.4 China Hemophilia Gene Therapy Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 China Hemophilia Gene Therapy Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 China Hemophilia Gene Therapy Market Revenues & Volume, By Specialized Clinics, 2021 - 2031F |
6.4.4 China Hemophilia Gene Therapy Market Revenues & Volume, By Home Care Settings, 2021 - 2031F |
7 China Hemophilia Gene Therapy Market Import-Export Trade Statistics |
7.1 China Hemophilia Gene Therapy Market Export to Major Countries |
7.2 China Hemophilia Gene Therapy Market Imports from Major Countries |
8 China Hemophilia Gene Therapy Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for hemophilia gene therapy |
8.2 Number of gene therapy research publications from Chinese institutions |
8.3 Funding and investments in hemophilia gene therapy research and development in China |
9 China Hemophilia Gene Therapy Market - Opportunity Assessment |
9.1 China Hemophilia Gene Therapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 China Hemophilia Gene Therapy Market Opportunity Assessment, By Hemophilia Type, 2021 & 2031F |
9.3 China Hemophilia Gene Therapy Market Opportunity Assessment, By Administration Method, 2021 & 2031F |
9.4 China Hemophilia Gene Therapy Market Opportunity Assessment, By End user, 2021 & 2031F |
10 China Hemophilia Gene Therapy Market - Competitive Landscape |
10.1 China Hemophilia Gene Therapy Market Revenue Share, By Companies, 2024 |
10.2 China Hemophilia Gene Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here